SUNNYVALE, Calif.--(BUSINESS WIRE)--PQ Bypass, Inc., today announced it has received conditional approval of its investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) ...

A study of a novel percutaneous technique for treating long, complex occlusions of the superficial femoral artery met its primary safety and efficacy endpoints, according to findings presented at the ...

BLACKFOOT —Bingham Healthcare is proud to announce that David Shelley MD, a leading vascular specialist, has successfully performed a percutaneous arterial bypass (PTAB) procedure using the innovative ...

One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--PQ Bypass, today announced CE (Conformité Européenne) Mark approval for a trio of proprietary devices: TORUS™ Stent Graft System, PQ Snare, and PQ Crossing Device, ...

In patients with common femoral artery disease, balloon angioplasty plus stenting if needed achieves acceptable restenosis and target lesion revascularization (TLR) rates at 1 year. The results render ...

Bypass surgery, also known as coronary artery bypass grafting, is one of the most common operations worldwide. In the US, there are approximately 200,000 bypass surgeries each year, according to the ...